EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

“Yong” syndrome–cGAS-STING axis: a TCM syndrome-based hypothesis for overcoming primary anti-PD-1 resistance in gastric cancer

Yinghou Wang, Guozheng Liu, Yan Li, Lijie Zhou, Yanyan Chen, Ye Zhang, Jingdong Xiao, Yajie Zhang

Journal for ImmunoTherapy of Cancer · 2026-08 · 14 (8) · e015810

DOI: 10.1136/jitc-2026-015810 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal for ImmunoTherapy of Cancer, online erschienen am 04.08.2026. Verfasst von Yinghou Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, Liaoning University of Traditional Chinese Medicine, Shenyang, Liaoning, China. Hauptthemen laut MEDLINE: Stomach Neoplasms, Membrane Proteins, Programmed Cell Death 1 Receptor, Nucleotidyltransferases. Die Arbeit nennt 8 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Doctoral Startup Foundation of Liaoning Province, the Key R&D Project of Liaoning Provincial Science and Technology Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Gastric cancer (GC) remains a major clinical challenge, with most patients exhibiting primary resistance to anti-programmed cell death protein-1 (anti-PD-1) immunotherapy and a lack of effective predictive biomarkers. Most advanced GC presents as immune-excluded “cold” tumors that respond poorly to immune checkpoint blockade. Traditional Chinese medicine (TCM) “Yong (abscess)” syndrome and the “treating GC as Yong” theory are widely applied in clinical practice, yet lack clear molecular and immunological mechanisms. Here, by translating these clinical observations into modern biological terms, we present an original, testable hypothesis proposing the “Yong” syndrome–cyclic GMP-AMP synthase-stimulator of interferon genes (cGAS-STING) axis as the central molecular bridge connecting TCM syndrome subtypes, GC histological subtypes, and TME reprogramming. We hypothesize that heat-clearing and blood-activating TCM monomers activate cGAS-STING in a subtype-selective manner to convert “cold” tumors to “hot” immunogenic phenotypes, directly addressing the critical clinical dilemmas of primary anti-PD-1 resistance and insufficient biomarkers in GC immunotherapy. This hypothesis translates universal cGAS-STING mechanisms into a clinically actionable, syndrome-based precision strategy for GC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Stomach NeoplasmsMembrane ProteinsProgrammed Cell Death 1 ReceptorNucleotidyltransferasesMedicine, Chinese TraditionalDrug Resistance, NeoplasmImmune Checkpoint InhibitorsHumanscGAS-STING Signaling PathwayCyclic Guanosine Monophosphate-Adenosine Monophosphate SynthaseSTING ProteinTumor Microenvironment

Stichwörter der Autor:innen

Gastric CancerImmunotherapyTumor microenvironment - TME

Substanzen

Membrane ProteinsProgrammed Cell Death 1 ReceptorNucleotidyltransferasesCyclic Guanosine Monophosphate-Adenosine Monophosphate SynthasePDCD1 protein, humancGAS protein, humanSTING ProteinImmune Checkpoint InhibitorsSTING1 protein, human

Autor:innen und Institutionen

  • Department of General Surgery, Liaoning University of Traditional Chinese Medicine, Shenyang, Liaoning, China.
  • Department of Internal Medicine, Liaoning University of Traditional Chinese Medicine Affiliated Hospital, Shenyang, Liaoning, China.
  • Liaoning University of Traditional Chinese Medicine Affiliated Hospital, Shenyang, Liaoning, China.
  • Department of Gastroenterology, Shengjing Hospital of China Medical University, Shenyang, Liaoning, China.
  • Department of Gastroenterology, Shengjing Hospital of China Medical University, Shenyang, Liaoning, China cmudoctorzyj@163.com.

Förderung

  • Doctoral Startup Foundation of Liaoning Province
  • the Key R&D Project of Liaoning Provincial Science and Technology Program

Zitieren

APA

Wang, Y., Liu, G., Li, Y., Zhou, L., Chen, Y., Zhang, Y., Xiao, J., & Zhang, Y. (2026). “Yong” syndrome–cGAS-STING axis: a TCM syndrome-based hypothesis for overcoming primary anti-PD-1 resistance in gastric cancer. Journal for ImmunoTherapy of Cancer, 14(8), e015810. https://doi.org/10.1136/jitc-2026-015810

Vancouver

Wang Y, Liu G, Li Y, Zhou L, Chen Y, Zhang Y, et al. “Yong” syndrome–cGAS-STING axis: a TCM syndrome-based hypothesis for overcoming primary anti-PD-1 resistance in gastric cancer. Journal for ImmunoTherapy of Cancer. 2026;14(8):e015810. doi:10.1136/jitc-2026-015810

BibTeX
@article{Wang2026,
  author = {Wang, Yinghou and Liu, Guozheng and Li, Yan and Zhou, Lijie and Chen, Yanyan and Zhang, Ye and Xiao, Jingdong and Zhang, Yajie},
  title = {“Yong” syndrome–cGAS-STING axis: a TCM syndrome-based hypothesis for overcoming primary anti-PD-1 resistance in gastric cancer},
  journal = {Journal for ImmunoTherapy of Cancer},
  year = {2026},
  volume = {14},
  number = {8},
  pages = {e015810},
  doi = {10.1136/jitc-2026-015810}
}
Kostenlos starten →